These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2662317

  • 21. Immune reactive proteins in renal cell carcinoma patients treated by IFN alpha alone or in combination with vinblastine.
    Juranić Z, Stanojević-Bakić N, Maletić V, Borkovacki R.
    Neoplasma; 1994; 41(4):229-32. PubMed ID: 7935998
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [Abstract] [Full Text] [Related]

  • 24. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
    Kanno H, Kitami K, Senga Y, Takahashi T, Nagashima Y.
    Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
    [Abstract] [Full Text] [Related]

  • 25. Cytotoxic chemotherapy for advanced renal cell carcinoma.
    Yagoda A, Petrylak D, Thompson S.
    Urol Clin North Am; 1993 May; 20(2):303-21. PubMed ID: 8493752
    [Abstract] [Full Text] [Related]

  • 26. Interferon in metastatic renal cell carcinoma.
    Fosså SD.
    Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
    [Abstract] [Full Text] [Related]

  • 27. Limitations of surgical curability in renal cell carcinoma.
    Geboers AD, Debruyne FM.
    Prog Clin Biol Res; 1992 Apr; 378():175-86. PubMed ID: 1301579
    [No Abstract] [Full Text] [Related]

  • 28. [Immunotherapeutic treatment for metastatic renal carcinoma].
    Hidalgo Pardo F, Gutiérrez Sanz-Gadea C, Rebassa Llull MJ, García Bueno JM, Mus Malleu A, Losada González GP, Ozonas Moragues M.
    Actas Urol Esp; 1998 Jan; 22(1):29-33. PubMed ID: 9542189
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Embolization for renal carcinoma].
    Li S, Dong Z, Li J.
    Zhonghua Wai Ke Za Zhi; 1998 Feb; 36(2):101-2. PubMed ID: 11715549
    [Abstract] [Full Text] [Related]

  • 31. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
    Wood CG.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.
    Urol Oncol; 2009 Jan 15; 27(6):598-603. PubMed ID: 18818106
    [Abstract] [Full Text] [Related]

  • 33. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ, Belldegrun AS, Figlin RA.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [Abstract] [Full Text] [Related]

  • 34. Immunotherapy for renal cell cancer in the era of targeted therapy.
    Coppin C.
    Expert Rev Anticancer Ther; 2008 Jun 15; 8(6):907-19. PubMed ID: 18533800
    [Abstract] [Full Text] [Related]

  • 35. Presurgical therapy in metastatic renal cell carcinoma.
    Jonasch E.
    Expert Rev Anticancer Ther; 2007 Jan 15; 7(1):73-8. PubMed ID: 17187521
    [Abstract] [Full Text] [Related]

  • 36. [Metastatic cancer of the kidney. What can be done today?].
    Chautard D, Lanson Y.
    J Urol (Paris); 1988 Jan 15; 94(7):307-16. PubMed ID: 3065413
    [Abstract] [Full Text] [Related]

  • 37. [Bilateral synchronous renal cell carcinoma: report of three cases].
    Nakatsuji H, Yamashita Y, Karashima T, Hashine K, Sumiyoshi Y.
    Hinyokika Kiyo; 1999 Oct 15; 45(10):695-8. PubMed ID: 10586361
    [Abstract] [Full Text] [Related]

  • 38. Opportunities and obstacles to combination targeted therapy in renal cell cancer.
    Sosman JA, Puzanov I, Atkins MB.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):764s-769s. PubMed ID: 17255307
    [Abstract] [Full Text] [Related]

  • 39. For: Radical nephrectomy in the setting of metastatic renal cell cancer: proceed judiciously.
    Aron M, Gill IS.
    J Urol; 2009 Sep 15; 182(3):832-3. PubMed ID: 19643447
    [No Abstract] [Full Text] [Related]

  • 40. [A case of renal cell carcinoma similar to rhabdoid tumor of kidney in an adult; trial of radiation and chemotherapy].
    Sano K, Kawasaki C, Sato K, Iwasaki A, Ishizuka E.
    Hinyokika Kiyo; 1991 Dec 15; 37(12):1699-702. PubMed ID: 1785395
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.